What exactly changed in the Morgan Stanley note on Feb 6, 2026?

Morgan Stanley maintained an Overweight rating and raised the price target to **$310** from **$300**. The update left the rating unchanged but adjusted valuation assumptions. The RNR analyst rating shows continued confidence without a new buy call.

How should investors use the RNR analyst rating in portfolio decisions?

Use the RNR analyst rating as one data point. Combine it with balance sheet metrics, catastrophe trends, and your time horizon. A maintained Overweight suggests relative outperformance but not guaranteed results.

Does the price target raise imply immediate upside for RNR shareholders?

A **$310** target narrows or expands upside depending on current price. The RNR analyst rating raise is supportive, but short-term price moves can reflect macro and sector flows. Review risk tolerance before trading.

Where can I read the original analyst note cited in this article?

The Morgan Stanley update was summarized by [TheFly](https://thefly.com/permalinks/entry.php/id4287596/4261286394/RNR-RenaissanceRe-price-target-raised-by--at-Morgan-Stanley-heres-why). For live quotes and additional data check the RNR page on Meyka at [RNR on Meyka](https://meyka.ai/stocks/RNR).

Analyst Ratings

Morgan Stanley Maintains Overweight on RenaissanceRe Holdings Ltd (RNR) Feb $310

ByDanny Kontos February 9, 2026February 9, 2026

Morgan Stanley on February 6, 2026 maintained an Overweight rating on RenaissanceRe Holdings Ltd. (RNR) and raised the price target to $310. The RNR analyst rating update signals continued confidence in RenaissanceRe’s reinsurance franchise and capital return ability. Morgan Stanley left the rating unchanged while nudging valuation assumptions higher, citing underwriting discipline and favorable market spreads. Investors should view the note as a reaffirmation rather than a directional shift, but the raised price target tightens the upside case versus prior guidance.